Somaxon Pharmaceuticals Inc. got approval for its insomnia drug Silenor after three tries from the FDA. The company had initially sent their drug application as early as January, 2008 which eventually got declined. Somaxon resubmitted its application on January 21, 2010, which was considered as Class 1 resubmission with a two-month review cycle resulting in a decision date by March 21, 2010.
Silenor has not been designated as a controlled substance by the U.S. Drug Enforcement Administratio
One thing you cannot avoid when you are resting would be the sudden attack of allergies. Normally, this pertains to sneezing or any form of irritating manner that can most likely be a problem for health reasons and sleep. But with the SneezerBeam, all that could possibly be addressed.
SneezerBeam is a non-invasive light therapy that treats allergic symptoms such as congestion, runny nose, watery eyes and a headache using only light. SneezerBeam works by using two combined beams of light to inhibit the cells in your nose that release histamine, which is at the center of what
